Introduction
TABLE OF CONTENTS
6 TO 50
383 TO 406
Goodwill is not amortised. It is tested for impairment at least once a year during the fourth quarter or whenever an adverse event occurs. Adverse events may result among other things from an increase in market interest rates or from a decrease in actual net sales or operational profit compared to forecasts.
Impairment tests consist of comparing the carrying amount of assets including goodwill and brands with the recoverable amount of each Cash Generating Unit. A Cash Generating Unit corresponds to one or more worldwide brands. A Cash Generating Unit can contain several brands in case of similar marketing position or depending on organisational criteria and particularly when distribution circuits and commercial/management structures are pooled. Recoverable values are determined on the basis of discounted operating cash flow forecasts covering a period of 10 years (the period considered necessary for the strategic positioning of an acquisition) and a terminal value. The cash flows are determined in the currencies of the countries in question and are translated, in the same way as the net carrying amounts to which they are compared, at the estimated exchange rate for the following year. The discount rate used for these calculations is based on the weighted average cost of capital (WACC), which amounted to 8.3% in 2024, to 9.2% in 2023 and 8.8% in 2022 for amounts in euro, adjusted where appropriate by a country risk premium according to the geographic zones concerned. The discount rates are post-tax rates applied to post-tax cash flows, and result in recoverable amounts identical to those obtained by applying pre-tax rates to pre-tax cash flows. The assumptions adopted in terms of sales growth and terminal values are reasonable and consistent with the available market data (generally 2.5% for Europe and 3% for the rest of the world for terminal values except in specific cases).
The use of discounted cash flow forecasts is preferred in order to determine recoverable amounts, unless details of similar recent transactions are readily available.
Impairment charged against goodwill cannot be reversed.
Impairment tests of Cash Generating Units for which the carrying amount of goodwill and intangible assets with indefinite useful lives is significant, are carried out based on the following data and assumptions:
€ millions | 2024 | 2023 | 2022 |
---|---|---|---|
Net carrying amount of goodwill and brands with an indefinite useful life(1) | |||
Retail Skincare (Luxe) | Retail Skincare (Luxe) 2024 2,473.5 |
Retail Skincare (Luxe) 2023 2,431.2 |
Retail Skincare (Luxe) 2022 157.2 |
Perfumes | Perfumes 2024 1,844.0 |
Perfumes 2023 1,842.0 |
Perfumes 2022 1,842.2 |
L'Oréal Paris | L'Oréal Paris 2024 1,259.7 |
L'Oréal Paris 2023 1,227.7 |
L'Oréal Paris 2022 1,235.7 |
Mass Market Makeup | Mass Market Makeup 2024 1,132.1 |
Mass Market Makeup 2023 1,086.7 |
Mass Market Makeup 2022 1,109.5 |
Make up (Luxe) | Make up (Luxe) 2024 971.2 |
Make up (Luxe) 2023 940.2 |
Make up (Luxe) 2022 1,229.8 |
SkinCeuticals/Skinbetter Science | SkinCeuticals/Skinbetter Science 2024 999.7 |
SkinCeuticals/Skinbetter Science 2023 921.5 |
SkinCeuticals/Skinbetter Science 2022 938.2 |
Lancôme | Lancôme 2024 869.4 |
Lancôme 2023 845.0 |
Lancôme 2022 850.8 |
CeraVe | CeraVe 2024 852.9 |
CeraVe 2023 823.2 |
CeraVe 2022 839.0 |
Redken/PureOlogy | Redken/PureOlogy 2024 833.3 |
Redken/PureOlogy 2023 789.6 |
Redken/PureOlogy 2022 802.4 |
Matrix | Matrix 2024 773.3 |
Matrix 2023 734.1 |
Matrix 2022 755.4 |
Skincare (Luxe) | Skincare (Luxe) 2024 722.4 |
Skincare (Luxe) 2023 712.3 |
Skincare (Luxe) 2022 733.2 |
YSL Beauté | YSL Beauté 2024 536.7 |
YSL Beauté 2023 536.2 |
YSL Beauté 2022 536.4 |
Stylenanda | Stylenanda 2024 464.0 |
Stylenanda 2023 478.0 |
Stylenanda 2022 493.8 |
Garnier | Garnier 2024 424.7 |
Garnier 2023 440.7 |
Garnier 2022 436.6 |
NYX Professional Makeup | NYX Professional Makeup 2024 457.8 |
NYX Professional Makeup 2023 433.3 |
NYX Professional Makeup 2022 446.4 |
L'Oréal Professionnel/Kérastase | L'Oréal Professionnel/Kérastase 2024 449.8 |
L'Oréal Professionnel/Kérastase 2023 422.4 |
L'Oréal Professionnel/Kérastase 2022 429.5 |
Vichy | Vichy 2024 328.8 |
Vichy 2023 322.4 |
Vichy 2022 327.3 |
Multicultural Brands | Multicultural Brands 2024 62.3 |
Multicultural Brands 2023 106.1 |
Multicultural Brands 2022 111.8 |
(1) Including acquisitions during the year.
Due to a slowdown in the activity of the Multicultural Brands CGU leading to a downward review of the ambitions of the business plan, an impairment loss was recorded for €50 million.
The recoverable value of the Multicultural Brands Cash Generating Unit amounts to €106 million at the end of December 2024.
The discount ratess used at 31 December 2024 for this test were between 6.1% and 15.3% including 8.3% for the USA and 8.3% for international. This rate is the result of specific rates for each market or geographic zone based on the risks they represent.
At 31 December 2024, a 1% increase in the discount rate on all the Group’s Cash Generating Units would lead to an impairment loss risk of around €33.7 million.